Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC.

Falk Roeder; Carmen Timke; Ladan Saleh-Ebrahimi; Lutz Schneider; Thilo Hackert; Werner Hartwig; Annette Kopp-Schneider; Frank W Hensley; Markus W Buechler; Juergen Debus; Peter E Huber; Jens Werner

doi:10.1186/1471-2407-12-112

Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC.

Falk Roeder^* (First author)
, Carmen Timke
, Ladan Saleh-Ebrahimi
, Lutz Schneider
, Thilo Hackert
, Werner Hartwig
, Annette Kopp-Schneider
, Frank W Hensley
, Markus W Buechler
, Juergen Debus
, Peter E Huber
, Jens Werner

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

12 Citations (Web of Science)

Original language	English
Pages (from-to)	112
Journal	BMC CANCER
Volume	12
DOIs	https://doi.org/10.1186/1471-2407-12-112
Publication status	Published - 2012

Keywords

PREOPERATIVE RADIOTHERAPY
RECTAL-CANCER
RESECTION MARGINS
IMPROVED SURVIVAL
ADENOCARCINOMA
CHEMORADIATION
QUESTIONNAIRE
CHEMOTHERAPY
CARCINOMA

Access to Document

10.1186/1471-2407-12-112

Cite this

Roeder, F., Timke, C., Saleh-Ebrahimi, L., Schneider, L., Hackert, T., Hartwig, W., Kopp-Schneider, A., Hensley, F. W., Buechler, M. W., Debus, J., Huber, P. E., & Werner, J. (2012). Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC. BMC CANCER, 12, 112. https://doi.org/10.1186/1471-2407-12-112

@article{c00bba3f03404aafa84581eec39526ff,

title = "Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC.",

keywords = "PREOPERATIVE RADIOTHERAPY, RECTAL-CANCER, RESECTION MARGINS, IMPROVED SURVIVAL, ADENOCARCINOMA, CHEMORADIATION, QUESTIONNAIRE, CHEMOTHERAPY, CARCINOMA",

author = "Falk Roeder and Carmen Timke and Ladan Saleh-Ebrahimi and Lutz Schneider and Thilo Hackert and Werner Hartwig and Annette Kopp-Schneider and Hensley, \{Frank W\} and Buechler, \{Markus W\} and Juergen Debus and Huber, \{Peter E\} and Jens Werner",

year = "2012",

doi = "10.1186/1471-2407-12-112",

language = "English",

volume = "12",

pages = "112",

journal = "BMC CANCER",

issn = "1471-2407",

publisher = " BioMed Central",

}

Roeder, F, Timke, C, Saleh-Ebrahimi, L, Schneider, L, Hackert, T, Hartwig, W, Kopp-Schneider, A, Hensley, FW, Buechler, MW, Debus, J, Huber, PE & Werner, J 2012, 'Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC.', BMC CANCER, vol. 12, pp. 112. https://doi.org/10.1186/1471-2407-12-112

Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC. / Roeder, Falk (First author); Timke, Carmen; Saleh-Ebrahimi, Ladan et al.
In: BMC CANCER, Vol. 12, 2012, p. 112.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC.

AU - Roeder, Falk

AU - Timke, Carmen

AU - Saleh-Ebrahimi, Ladan

AU - Schneider, Lutz

AU - Hackert, Thilo

AU - Hartwig, Werner

AU - Kopp-Schneider, Annette

AU - Hensley, Frank W

AU - Buechler, Markus W

AU - Debus, Juergen

AU - Huber, Peter E

AU - Werner, Jens

PY - 2012

Y1 - 2012

KW - PREOPERATIVE RADIOTHERAPY

KW - RECTAL-CANCER

KW - RESECTION MARGINS

KW - IMPROVED SURVIVAL

KW - ADENOCARCINOMA

KW - CHEMORADIATION

KW - QUESTIONNAIRE

KW - CHEMOTHERAPY

KW - CARCINOMA

U2 - 10.1186/1471-2407-12-112

DO - 10.1186/1471-2407-12-112

M3 - Original Article

C2 - 22443802

SN - 1471-2407

VL - 12

SP - 112

JO - BMC CANCER

JF - BMC CANCER

ER -